La aprobacin otorgada a Novo Nordisk ampla el uso indicado del agonista de GLP-1 para incluir dosis de 0,5, 1,0 y 2,0 mg para el tratamiento de la DMT2, as como indicaciones para reducir el riesgo de eventos cardiovasculares adversos mayores en adultos con DMT2 y enfermedad cardiovascular
Insurance coverage is inconsistent, particularly for weight loss versus diabetes indications
doi: 10.1136/bmj.315.7103.279 7 YangJCummingsEAO'connellCJangaardK
This is especially important if insomnia begins after a dose change, if you cannot maintain hydration, or if you have diabetes medicines that can lower glucose
The drug itself is identical
The website owner assumes no responsibility for any potential damages or harm resulting from the use of the information contained on this website, nor for any misuse of the products offered through it